¡¾²Î¿¼ÎÄÏס¿

  ¡¡1 Bataille B, Delwail V, Menet E, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000;92:261ª²266

¡¡¡¡2 Buggage RR, Chan CC, Nussenblatt RB. Ocular manifestations of central nervous system lymphoma. Curr Opin Oncol 2001;13:137ª²142

¡¡¡¡3 DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114ª²123

¡¡¡¡4 Corn BW, Marcus SM, Topham A, et al. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 1997;79:2409ª²2413

¡¡¡¡5 Eby NL, Grufferman S, Flannelly CM, et al. Increasing incidence of primary brain lymphoma in the US. Cancer 1988;62:2461ª²2465

¡¡¡¡6 Thomas JO. Acquired immunodeficiency syndromeª²associated cancers in subª²Saharan Africa. Semin Oncol 2001;28:198ª²206

¡¡¡¡7 Nasir S, DeAngelis LM. Update on the management of primary CNS lymphoma. Oncology (Huntingt) 2000;14:228ª²234; discussion 237ª²242,244

¡¡¡¡8 Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol 1999;43:199ª²201

¡¡¡¡9 Cassoux N,Merleª²Beral H,Leblond V, et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm 2000;8:243ª²250

¡¡¡¡10 Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma: clinical and histopathologic diagnosis. Ophthalmology 1993;100:1399ª²406

¡¡¡¡11 Freeman LN, Schachat AP, Knox DL, et al. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 1987;94:1631ª²1639

¡¡¡¡12 Hormigo A, Abrey L, Heinemann MH, et al. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Br J Haematol 2004;126(2):202ª²208

¡¡¡¡13 Hormigo A, DeAngelis LM. Primary intraocular lymphoma: clinical features, diagnosis and treatment. Clin Lymphoma2003;4:22ª²29

¡¡¡¡14 Akpek EK, Ahmed I, Hochberg FH, et al. Intraocularª²central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 1999;106:1805ª²1810

¡¡¡¡15 Levyª²Clarke GA, Byrnes GA, Buggage RR, et al. Primary intraocular lymphoma diagnosed by fine needle aspiration biopsy of a subretinal lesion. Retina 2001;21:281ª²284

¡¡¡¡16 Velez G, de Smet MD, Whitcup SM, et al. Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature. Surv Ophthalmol 2000;44:518ª²526

¡¡¡¡17 Velez G, Chan CC, Csaky KG. Fluorescein angiographic findings in primary intraocular lymphoma. Retina 2002;22:37ª²43

¡¡¡¡18 Davis JL. Diagnosis of intraocular lymphoma. Ocul Immunol Inflamm 2004;12:7ª²16

¡¡¡¡19 Chan CC. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc 2003;101:275ª²292

¡¡¡¡20 Whitcup SM, Chan CC, Buggage RR, et al. Improving the diagnostic yield of vitrectomy for intraocular lymphoma. Arch Ophthalmol 2000;118:446

¡¡¡¡21 Davis JL,Solomon D,Nussenblatt RB, et al. Immunocytochemical staining of vitreous cells:indications, techniques, and results. Ophthalmology 1992;99:250ª²256

¡¡¡¡22 Whitcup SM, Starkª²Vancs V, Wittes RE, et al. Association of interleukinª²10 in the vitreous and cerebral spinal fluid and primary central nervous system lymphoma. Arch Ophthalmol 1997;115:1157ª²1160

¡¡¡¡23 Tuaillon N, Chan CC. Molecular analysis of primary central nervous system and primary intraocular lymphoma. Curr Mol Med 2001;1:259ª²272

¡¡¡¡24 Davis JL, Viciana AL, Ruiz P. Diagnosis of intraocular lymphoma by flow cytometry. Am J Ophthalmol 1997;124:362ª²372

¡¡¡¡25 Chan CC, Shen DF. Newer methodologies in immunohistochemistry and diagnosis. In:BenEzra D, editor. Uveitis update, Volume 31. Basel (Switzerland): Karger; 1999:1ª²13

¡¡¡¡26 Merleª²Beral H, Davi F, Cassoux N, et al. Biological diagnosis of primary intraocular lymphoma. Br J Haematol 2004;124:469ª²473

¡¡¡¡27 Coupland SE, Bechrakis NE, Anastassiou G, et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Graefes Arch Clin Exp Ophthalmol 2003;241:860ª²870

¡¡¡¡28 Gorochov G,Parizot C,Bodaghi B, et al. Characterization of vitreous Bª²cell infiltrates in patients with primary ocular lymphoma, using CDR3 size polymorphism analysis of antibody transcripts. Invest Ophthalmol Vis Sci 2003;44:5235ª²5241

¡¡¡¡29 Sandor V, Starkª²Vancs V, Pearson D, et al. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma [comments]. J Clin Oncol 1998;16:3000ª²3006

¡¡¡¡30 De Smet MD. Management of non Hodgkin¬ðs intraocular lymphoma with intravitreal methotrexate. Bull Soc Belge Ophtalmol 2001;279:91ª²95

¡¡¡¡31 Smith JR, Rosenbaum JT, Wilson DJ, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 2002;109:1709ª²1716

¡¡¡¡32 Camilleriª²Broet S, Vanderwerff H, Caldwell E, et al. Distinet allerations in mitochondrial mass and function characterize different models of apoptosis. Exp Cell Res 1998;39:277ª²292

¡¡¡¡33 Larocca LM, Capello D, Rinelli A, et al. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal centerª²related B cells. Blood 1998;92:1011ª²1019

¡¡¡¡34 Rubenstein J, Fridlyand J, Shen A, et al. Gene expression and angiotropism in primary CNS lymphoma. Blood 2006;107(9):3716ª²3723

¡¡¡¡35 Hegde U, Filie A, Little RF, et al. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive Bª²cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood 2005;105:496ª²502

¡¡¡¡36 Kaminski MS, Zelenetz AD, Press OW, et al. Pivotal study of iodine I 131 tositumomab for chemotherapyª²refractory lowª²grade or transformed lowª²grade Bª²cell nonª²Hodgkin's lymphomas. J Clin Oncol 2001;19:3918ª²3928

¡¡¡¡37 Li JJ, Zhang JJ. Intraocular lymphoma. Int J Ophthalmol(Guoji Yanke Zazhi) 2005;5(6):1235ª²1238

¡¡¡¡38 FitzGerald DJ, Kreitman R, Wilson W, et al. Recombinant immunotoxins for treating cancer. Int J Med Microbiol 2004;293:577ª²582

ÉÏÒ»Ò³  [1] [2] [3] [4]